Fig. 1 · Structure
Documents & Downloads
Ritivixibat
IBAT Inhibitor
Ritivixibat is an inhibitor of the ileal bile acid transporter (IBAT), functioning as a bile acid modulator. This compound has shown promise in the investigation of cardiovascular diseases, disorders of fatty acid metabolism and glucose utilization, as well as gastrointestinal and liver diseases. Its ability to modulate bile acid recycling makes it a valuable tool for research into related metabolic pathways and therapeutic interventions.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| Actions | Inhibitor |
| CAS Number | 2460667-52-9 |
| Applications | IBAT Inhibitor |
| Formula | C26H36N2O5S2 |
| Molecular Weight | 520.70 |
| SMILES | O=C(CCOC1=C(SC)C=C(N(CC(CCCC)(CCCC)NS2(=O)=O)C3=CC=CC=C3)C2=C1)O |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.